Relationships between 2018 UNOS heart policy and transplant outcomes in metropolitan, micropolitan, and rural settings.

Health policy Healthcare disparities Heart transplant Rural health centers Socioeconomic factors

Journal

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
ISSN: 1557-3117
Titre abrégé: J Heart Lung Transplant
Pays: United States
ID NLM: 9102703

Informations de publication

Date de publication:
09 2022
Historique:
received: 07 06 2021
revised: 10 06 2022
accepted: 17 06 2022
pubmed: 27 7 2022
medline: 23 9 2022
entrez: 26 7 2022
Statut: ppublish

Résumé

In 2018, United Network for Organ Sharing (UNOS) extended the radius for which a heart transplant candidate can match with a donor, and outcomes across population densities are unknown. We sought to determine whether the policy change was associated with differences in heart transplant waitlist time or death post-transplant for patients from rural, micropolitan, and metropolitan settings. Using the Scientific Registry of Transplant Recipients, we evaluated U.S. adult patients listed for heart transplant from Janurary 2017 to September 2019 with follow-up through March 2020. Patients were stratified by home zip-codes to either metropolitan, micropolitan, or rural settings. Fine and Gray and Cox models were respectively used to estimate Sub-distribution hazard ratios (SHR) of heart transplant with death or removal from transplant list as a competing event, and HR of death post-transplant within population densities after versus before the UNOS policy change date, October 18, 2018. Analyses were adjusted for demographics, comorbidities, and labs. Among 8,747 patients listed for heart transplant, 84.7% were from metropolitan, 8.6% micropolitan, and 6.6% rural settings. The 2018 UNOS policy was associated with earlier receipt of heart transplant for metropolitan [SHR 1.56 (95% CI: 1.46-1.66)] and micropolitan [SHR 1.48 (95% CI: 1.21-1.82)] populations, but not significantly for rural [SHR 1.20 (95% CI: 0.93-1.54)]; however, the interaction between policy and densities was not significant (p = .14). Policy changes were not associated with risk of death post-transplant [metropolitan: HR 1.04 (95% CI: 0.80-1.34); micropolitan: HR 1.10 (95% CI: 0.55-2.23); rural: HR 1.04 (95% CI: 0.52-2.08); interaction p = .99]. The 2018 UNOS heart transplant policy was associated with earlier receipt of heart transplant and no difference in post-transplant survival within population densities. Additional follow-up is needed to determine whether improvements are sustained.

Sections du résumé

BACKGROUND
In 2018, United Network for Organ Sharing (UNOS) extended the radius for which a heart transplant candidate can match with a donor, and outcomes across population densities are unknown. We sought to determine whether the policy change was associated with differences in heart transplant waitlist time or death post-transplant for patients from rural, micropolitan, and metropolitan settings.
METHODS
Using the Scientific Registry of Transplant Recipients, we evaluated U.S. adult patients listed for heart transplant from Janurary 2017 to September 2019 with follow-up through March 2020. Patients were stratified by home zip-codes to either metropolitan, micropolitan, or rural settings. Fine and Gray and Cox models were respectively used to estimate Sub-distribution hazard ratios (SHR) of heart transplant with death or removal from transplant list as a competing event, and HR of death post-transplant within population densities after versus before the UNOS policy change date, October 18, 2018. Analyses were adjusted for demographics, comorbidities, and labs.
RESULTS
Among 8,747 patients listed for heart transplant, 84.7% were from metropolitan, 8.6% micropolitan, and 6.6% rural settings. The 2018 UNOS policy was associated with earlier receipt of heart transplant for metropolitan [SHR 1.56 (95% CI: 1.46-1.66)] and micropolitan [SHR 1.48 (95% CI: 1.21-1.82)] populations, but not significantly for rural [SHR 1.20 (95% CI: 0.93-1.54)]; however, the interaction between policy and densities was not significant (p = .14). Policy changes were not associated with risk of death post-transplant [metropolitan: HR 1.04 (95% CI: 0.80-1.34); micropolitan: HR 1.10 (95% CI: 0.55-2.23); rural: HR 1.04 (95% CI: 0.52-2.08); interaction p = .99].
CONCLUSIONS
The 2018 UNOS heart transplant policy was associated with earlier receipt of heart transplant and no difference in post-transplant survival within population densities. Additional follow-up is needed to determine whether improvements are sustained.

Identifiants

pubmed: 35882595
pii: S1053-2498(22)01994-5
doi: 10.1016/j.healun.2022.06.015
pmc: PMC9489641
mid: NIHMS1826793
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1228-1236

Subventions

Organisme : NHLBI NIH HHS
ID : K01 HL142848
Pays : United States
Organisme : NHLBI NIH HHS
ID : L30 HL148881
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL159216
Pays : United States
Organisme : NHLBI NIH HHS
ID : R56 HL159216
Pays : United States

Informations de copyright

Copyright © 2022 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Références

Am Heart J. 2012 Jul;164(1):80-6
pubmed: 22795286
Circulation. 2020 Mar 10;141(10):e615-e644
pubmed: 32078375
JAMA. 2011 Jul 6;306(1):45-52
pubmed: 21730240
Circ Heart Fail. 2013 Jul;6(4):763-72
pubmed: 23674362
Am J Transplant. 2020 Oct;20(10):2781-2790
pubmed: 32406597
Am J Transplant. 2022 Jun;22(6):1683-1690
pubmed: 34951528
J Heart Lung Transplant. 2020 Jan;39(1):1-4
pubmed: 31810767
JACC Heart Fail. 2020 Jul;8(7):548-556
pubmed: 32417413
Circulation. 2020 Dec 15;142(24):e454-e468
pubmed: 33170755
Circ Cardiovasc Qual Outcomes. 2020 Aug;13(8):e000089
pubmed: 32673512
JACC Heart Fail. 2014 Feb;2(1):73-83
pubmed: 24611131
J Am Heart Assoc. 2019 Nov 19;8(22):e013592
pubmed: 31707940
J Heart Lung Transplant. 2016 Jan;35(1):1-23
pubmed: 26776864
JAMA. 2008 Jan 9;299(2):202-7
pubmed: 18182602
N Engl J Med. 2019 Apr 25;380(17):1618-1627
pubmed: 30883052
Circulation. 2015 Sep 1;132(9):873-98
pubmed: 26240271
J Heart Lung Transplant. 2020 Jul;39(7):725-726
pubmed: 32307250
Circ Heart Fail. 2011 May;4(3):317-23
pubmed: 21430285
PLoS One. 2021 Mar 3;16(3):e0246813
pubmed: 33657143
J Heart Lung Transplant. 2017 Dec;36(12):1311-1318
pubmed: 29173394
JACC Heart Fail. 2017 Feb;5(2):136-147
pubmed: 28109783
Circ Cardiovasc Qual Outcomes. 2021 Feb;14(2):e007868
pubmed: 33567860
JAMA Cardiol. 2021 Feb 1;6(2):159-167
pubmed: 33112391

Auteurs

Khadijah Breathett (K)

Division of Cardiovascular Medicine, Krannert Cardiovascular Institute, Indiana University, Indianapolis. Electronic address: kbreath@iu.edu.

Shannon M Knapp (SM)

Statistics Consulting Lab, Bio5 Institute, University of Arizona, Tucson.

Daniel Addison (D)

Division of Cardiovascular Medicine, Ohio State University.

Amber Johnson (A)

Division of Cardiovascular Medicine, University of Pittsburgh.

Rashmee U Shah (RU)

Division of Cardiovascular Medicine, University of Utah.

Kelsey Flint (K)

Rocky Mountain Regional Veterans Affairs Medical Center, Cardiology Section and Division of Cardiovascular Medicine, University of Colorado.

Harriette G C Van Spall (HGC)

Department of Medicine and Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Nancy K Sweitzer (NK)

Division of Cardiovascular Medicine, Sarver Heart Center, University of Arizona, Tucson.

Sula Mazimba (S)

Division of Cardiovascular Medicine, University of Virginia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH